Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Petzold

Showing results (141-150 of 277) with videos related to

Pageof 28
Sort By:
JAMA Network Open|March 3, 2022
Associations of Alcohol Consumption and Smoking With Disease Risk and Neurodegeneration in Individuals With Multiple Sclerosis in the United KingdomIris Kleerekooper, Sharon Chua, Paul J Foster, et al.
Critical Care Medicine|December 17, 2002
Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot studyAxel Petzold, Alison J E Green, Geoff Keir, et al.
Critical Care (London, England)|January 22, 2014
Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot studyLuuk Wieske, Esther Witteveen, Axel Petzold, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromesJohannes Brettschneider, Axel Petzold, Sigurd D Süssmuth, et al.
Plos One|August 23, 2011
Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosisPetra Steinacker, Lubin Fang, Jens Kuhle, et al.
The Lancet. Neurology|September 26, 2022
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatmentJeffrey L Bennett, Fiona Costello, John J Chen, et al.
Neurochemical Research|December 31, 2010
Rostrocaudal dynamics of CSF biomarkersAndrew Tarnaris, Ahmed K Toma, Miles D Chapman, et al.
Neuro-Ophthalmology (Aeolus Press)|December 8, 2018
The Pulfrich Phenomenon: Practical Implications of the Assessment of Cases and Effectiveness of TreatmentJane Farr, Emily McGarva, Jenny Nij Bijvank, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layersDanko Coric, Lisanne J Balk, Merike Verrijp, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 23, 2009
A novel biomarker for retinal degeneration: vitreous body neurofilament proteinsAxel Petzold, Anselm Junemann, Konrad Rejdak, et al.
Pageof 28

Showing results (141-150 of 277) with videos related to

Sort By:
Pageof 28
JAMA Network Open|March 3, 2022
Associations of Alcohol Consumption and Smoking With Disease Risk and Neurodegeneration in Individuals With Multiple Sclerosis in the United KingdomIris Kleerekooper, Sharon Chua, Paul J Foster, et al.
Critical Care Medicine|December 17, 2002
Role of serum S100B as an early predictor of high intracranial pressure and mortality in brain injury: a pilot studyAxel Petzold, Alison J E Green, Geoff Keir, et al.
Critical Care (London, England)|January 22, 2014
Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot studyLuuk Wieske, Esther Witteveen, Axel Petzold, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromesJohannes Brettschneider, Axel Petzold, Sigurd D Süssmuth, et al.
Plos One|August 23, 2011
Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosisPetra Steinacker, Lubin Fang, Jens Kuhle, et al.
The Lancet. Neurology|September 26, 2022
Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatmentJeffrey L Bennett, Fiona Costello, John J Chen, et al.
Neurochemical Research|December 31, 2010
Rostrocaudal dynamics of CSF biomarkersAndrew Tarnaris, Ahmed K Toma, Miles D Chapman, et al.
Neuro-Ophthalmology (Aeolus Press)|December 8, 2018
The Pulfrich Phenomenon: Practical Implications of the Assessment of Cases and Effectiveness of TreatmentJane Farr, Emily McGarva, Jenny Nij Bijvank, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Cognitive impairment in patients with multiple sclerosis is associated with atrophy of the inner retinal layersDanko Coric, Lisanne J Balk, Merike Verrijp, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 23, 2009
A novel biomarker for retinal degeneration: vitreous body neurofilament proteinsAxel Petzold, Anselm Junemann, Konrad Rejdak, et al.
Pageof 28